The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 78.
233. lappuse
... considered from a chemical viewpoint , we find no substantial basis for holding the compounds , as chemical entities , to be other than obvious from the cited art . While the * * article does not refer to their com- pound as one of a ...
... considered from a chemical viewpoint , we find no substantial basis for holding the compounds , as chemical entities , to be other than obvious from the cited art . While the * * article does not refer to their com- pound as one of a ...
310. lappuse
... considered to be sufficient.123 12. ESSENTIAL FEATURES MUST BE INCLUDED ; CRITICAL LIMITS The specification must include all essential features . In a chemi- cal case this usually includes proportions of ingredients.124 In some cases ...
... considered to be sufficient.123 12. ESSENTIAL FEATURES MUST BE INCLUDED ; CRITICAL LIMITS The specification must include all essential features . In a chemi- cal case this usually includes proportions of ingredients.124 In some cases ...
697. lappuse
... considered . The court rejected this contention stating : " We see no reason to distinguish between chemical and bio- chemical properties and no reason or authority for this position has been presented to us . " We find it difficult to ...
... considered . The court rejected this contention stating : " We see no reason to distinguish between chemical and bio- chemical properties and no reason or authority for this position has been presented to us . " We find it difficult to ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention